pat_auckland said:I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.
Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.
pat_auckland said:I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.
Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.
wendy_avl said:I want to bring up the cardiovascular angle on cardiovascular risk.
Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling, reduces NLRP3 inflammasome activation, and decreases monocyte/macrophage adhesion to endothelium[1].
Clinical correlates: hsCRP reduction of 30-60% (consistently seen across trials), reduced carotid intima-media thickness, and decreased coronary plaque inflammation on PET imaging.
These anti-inflammatory effects likely contribute to the cardiovascular benefit seen in SELECT — and may explain benefits beyond what weight loss alone would predict.
wendy_avl said:I want to bring up the cardiovascular angle on cardiovascular risk.
6 month update on cardiovascular risk: down 51 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsFollowing on from wendy_avl — and this may be the naive question:
Did your prescriber agree with that reading, and if not what was their objection?